Keyphrases
Acute Myeloid Leukemia
75%
Bone Marrow
50%
Chronic Neutropenia
25%
Clinical Cytogenetics
25%
Clinical Improvement
25%
Clonal Cytogenetic Abnormalities
25%
Congenital Disorders
25%
Congenital Neutropenia
100%
Cytogenetic Remission
25%
Hematopoietic Growth Factors
25%
High Risk
25%
KRAS mutation
100%
Leukemic Transformation
25%
Leukemogenesis
25%
Long-term Treatment
25%
Malignant Transformation
100%
Monosomy 7
100%
Myelodysplastic Syndrome
75%
Myeloid Leukemia
25%
Myeloid Progenitors
25%
Myelopoiesis
25%
Neutrophil Count
25%
New Therapies
25%
Non-associated
25%
Quality of Life Improvement
25%
Recombinant Human Granulocyte Colony-stimulating Factor (rhG-CSF)
100%
Recurrent Infection
25%
Severe Disease
50%
Therapeutic Use
25%
Trisomy 5
25%
Medicine and Dentistry
Acute Myeloid Leukemia
60%
Drug Therapy
20%
Hemopoietic Growth Factor
20%
Infection
20%
Leukemogenesis
20%
Malignant Transformation
100%
Monosomy 7
100%
Myelodysplastic Syndrome
60%
Myeloid Leukemia
20%
Myelopoiesis
20%
Neutropenia
100%
Neutrophil
20%
Patient with Congenital Disorder
20%
Quality of Life
20%
Recombinant Granulocyte Colony Stimulating Factor
80%
Recurrent Infection
20%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Myeloid Leukemia
60%
Congenital Disorder
20%
Hemopoietic Growth Factor
20%
Infection
20%
Leukemogenesis
20%
Malignant Transformation
100%
Monosomy 7
100%
Myelodysplastic Syndrome
60%
Myeloid Leukemia
20%
Neutropenia
100%
Recombinant Granulocyte Colony Stimulating Factor
80%
Recurrent Infection
20%
Remission
20%
Therapeutic Use
20%
Immunology and Microbiology
Hemopoietic Growth Factor
25%
Myeloid
50%
Myelopoiesis
25%
Neutrophil Count
25%
Recombinant Granulocyte Colony Stimulating Factor
100%